Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients

Background. Hypertensive chronic kidney disease (CKD) patients often have sympathetic hyperactivity. In this pilot study, we evaluated the effect of 6 weeks treatment with